Spire Healthcare Group (LON:SPI) Rating Increased to Add at Peel Hunt

Peel Hunt upgraded shares of Spire Healthcare Group (LON:SPI) to an add rating in a research note published on Monday, Digital Look reports. They currently have GBX 155 ($2.03) price objective on the stock.

A number of other research analysts have also weighed in on the stock. UBS Group began coverage on shares of Spire Healthcare Group in a research note on Tuesday, July 2nd. They issued a neutral rating and a GBX 120 ($1.57) price objective for the company. Liberum Capital reiterated a hold rating on shares of Spire Healthcare Group in a research note on Monday, August 5th. Royal Bank of Canada reiterated an outperform rating and issued a GBX 149 ($1.95) price objective on shares of Spire Healthcare Group in a research note on Monday, September 9th. Finally, Barclays reiterated an underweight rating and issued a GBX 115 ($1.50) price objective on shares of Spire Healthcare Group in a research note on Friday, August 9th. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of GBX 130.44 ($1.70).

Spire Healthcare Group stock opened at GBX 115 ($1.50) on Monday. Spire Healthcare Group has a 1-year low of GBX 95.25 ($1.24) and a 1-year high of GBX 176 ($2.30). The firm has a market capitalization of $461.24 million and a price-to-earnings ratio of 41.07. The company has a current ratio of 1.44, a quick ratio of 0.95 and a debt-to-equity ratio of 48.52. The firm has a 50 day simple moving average of GBX 106.29 and a 200 day simple moving average of GBX 121.25.

The company also recently declared a dividend, which will be paid on Tuesday, December 10th. Stockholders of record on Thursday, November 14th will be given a dividend of GBX 1.30 ($0.02) per share. The ex-dividend date is Thursday, November 14th. This represents a dividend yield of 1.07%. Spire Healthcare Group’s dividend payout ratio (DPR) is currently 1.43%.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics in the United Kingdom. It provides a range of integrated surgical, medical, and diagnostic services. The company offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.

Featured Article: Buy Rating

Analyst Recommendations for Spire Healthcare Group (LON:SPI)

Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit